Why do babies smile when they interact with their parents? Could their smiles have a purpose? In the Sept. 23 issue of PLOS ONE, a team of computer scientists, roboticists and developmental psychologists confirm what most parents already suspect: when babies smile, they do so with a purpose—to make the person they interact with smile in return.
Scientists from UC San Diego are leading a novel pollution experiment at Imperial Beach, Coronado, and Tijuana. During the Cross Surfzone/Inner-shelf Dye Exchange project, researchers will perform three experiments releasing non-toxic bright pink fluorescent dye into beach waters and track its movements along the coast some 6.2-12.4 miles for nearly 36 hours.
The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.
In 2014, only 10 of the nation’s 132 pharmacy schools achieved a 100 percent pass rate on first-time attempts at the North American Pharmacist Licensure Examination (NAPLEX). The University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences was one of them, passing all 54 students who took the exam for the first time.
The theme for the University of California, San Diego’s 10th annual California Native American Day celebration is “Unsettled Stories: Reclaiming This Land,” and will include a kickoff event Sept. 25 as well as an undergraduate research symposium, a Native American film festival, spoken word performances, a powwow and more throughout the 2015-16 academic year.
Albert La Spada, MD, PhD, professor of pediatrics, cellular and molecular medicine and neurosciences at University of California, San Diego School of Medicine, has received a 2015 Harrington Scholar award to advance his work on a therapy for Spinocerebellar ataxia type 7 (SCA7), a rare but devastating neurological disorder that can lead to blindness and progressive loss of physical coordination.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
